American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (9) , 720-728
Abstract
No abstract availableKeywords
Funding Information
- Office of Naval Research
- National Heart, Lung, and Blood Institute
- Celgene
- National Institutes of Health (P01CA111412, R01AI128775, R01CA152108, R01CA215134, R01CA218285, R01CA231141, R01HL126589, R01HL129472, R01HL130388, R01HL131731, U01AI069197, U01AI126612, UG1HL06924)
- U.S. Department of War
- AbbVie
- CytoSen Therapeutics
- Boston Children's Hospital
- Karyopharm Therapeutics
- U.S. Public Health Service (U24CA076518)
- Kiadis Pharma
- Miltenyi Biotec
- Amgen
- Sanofi
- National Cancer Institute
- Leukemia and Lymphoma Society
- National Institute of Allergy and Infectious Diseases (HHSH250201700006C, OT3HL147741, U01HL128568, U24HL138660)
- Health Resources and Services Administration (N00014-20-1-2705, N00014-20-1-2832)
- Genentech Foundation
- Stanford University
- Incyte
- Gilead Sciences
- Legend Biotech (EcoR1)
- St. Baldrick's Foundation
- Daiichi-Sankyo
- Spectrum Pharmaceuticals
- Bayer Fund
- Angiocrine Bioscience
- GlaxoSmithKline
- Bristol-Myers Squibb
- Astellas Pharma US
- AstraZeneca
- Genentech
- Biomedical Advanced Research and Development Authority
- Merck
- TG Therapeutics
- Novartis
- Kite Pharma
- Roche
- Government of South Australia
- Jazz Pharmaceuticals
- Takeda Pharmaceuticals U.S.A.
- CSL Behring
- Janssen Pharmaceutica
- U.S. Navy
- Merck Sharp and Dohme United Kingdom
- Dana-Farber Cancer Institute
This publication has 35 references indexed in Scilit:
- Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Unresponsive Mantle Cell Lymphoma: A Cohort Analysis from the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2013
- American Society of Clinical Oncology Clinical Practice Guidelines: Formal Systematic Review–Based Consensus MethodologyJournal of Clinical Oncology, 2012
- Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL DatabaseBlood, 2012
- Long-term results of fludarabine/melphalan as a reduced-intensity conditioning regimen in mantle cell lymphoma: the GELTAMO experienceTherapeutic Advances in Hematology, 2011
- Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909Journal of Clinical Oncology, 2009
- Outcome of Deferred Initial Therapy in Mantle-Cell LymphomaJournal of Clinical Oncology, 2009
- A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long‐term follow‐up in newly diagnosed mantle cell lymphomaBritish Journal of Haematology, 2007
- Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkBlood, 2005
- Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphomaBlood, 2004
- Nonablative Allogeneic Stem-Cell Transplantation for Advanced/Recurrent Mantle-Cell LymphomaJournal of Clinical Oncology, 2003